This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Norris, R. M. Articles by Small, C. W. Search for Related Content PubMed PubMed Citation Articles by Norris, R. M. Articles by Small, C. W.

Circulation, Vol 51, 614-620, Copyright © 1975 by American Heart Association

ARTICLES

Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction

RM Norris, RM Whitlock, C Barratt-Boyes and CW Small

A modified method for the measurement of total creatine phosphokinase release from venous blood samples taken four-hourly after myocardial infarction has been used in 43 patients admitted to a Coronary Care Unit. The fractional decay rate (Kd) of enzyme activity has been measured by a standardized method in each patient, and accuracy of the calculation of total enzyme release has been improved by allowance for individual variations in decay rate, and discarding of data from which decay rates cannot be measured within confidence limits of less than plus or minus 15 per cent. Total enzyme release was greater in cases of transmural infarction than in patients with subendocardial infarction, and showed a good positive correlation with clinical indices of the extent of myocardial damage. As noted by previous workers, this method allows for the measurement of the rate as well as the extent of enzyme release, and so should prove useful in the clinical evaluation of therapeutic agents which might accelerate or retard the rate of myocardial necrosis in patients with acute myocardial infarction.

This article has been cited by other articles:

				A. Schomig, G. Ndrepepa, and A. Kastrati Mechanical Reperfusion More Than 12 Hours After Acute Myocardial Infarction--Reply JAMA, October 26, 2005; 294(16): 2031 - 2032. [Full Text] [PDF]

				S. Savonitto, C. B. Granger, D. Ardissino, L. Gardner, C. Cavallini, M. Galvani, F. Ottani, H. D. White, P. W. Armstrong, E. M. Ohman, et al. The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes J. Am. Coll. Cardiol., January 2, 2002; 39(1): 22 - 29. [Abstract] [Full Text] [PDF]

				J. H. Alexander, R. A. Sparapani, K. W. Mahaffey, J. W. Deckers, L. K. Newby, E. M. Ohman, R. Corbalan, S. L. Chierchia, J. B. Boland, M. L. Simoons, et al. Association Between Minor Elevations of Creatine Kinase-MB Level and Mortality in Patients With Acute Coronary Syndromes Without ST-Segment Elevation JAMA, January 19, 2000; 283(3): 347 - 353. [Abstract] [Full Text] [PDF]

				T. Murakami, S. Kusachi, M. Murakami, I. Sano, T. Uesugi, M. Murakami, R. Hirami, A. Kajiyama, J. Kondo, and T. Tsuji Time-dependent changes of serum carboxy-terminal peptide of type I procollagen and carboxy-terminal telopeptide of type I collagen concentrations in patients with acute myocardial infarction after successful reperfusion: correlation with left ventricular volume indices Clin. Chem., December 1, 1998; 44(12): 2453 - 2461. [Abstract] [Full Text] [PDF]

				L. Coudrey The Troponins Arch Intern Med, June 8, 1998; 158(11): 1173 - 1180. [Full Text] [PDF]

				L. V. Philosophov Bayesian Decision Making Based on Measurements Containing Errors Med Decis Making, August 1, 1995; 15(3): 264 - 275. [Abstract] [PDF]